1219 related articles for article (PubMed ID: 24412603)
1. Macrophage heterogeneity in liver injury and fibrosis.
Tacke F; Zimmermann HW
J Hepatol; 2014 May; 60(5):1090-6. PubMed ID: 24412603
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice.
Baeck C; Wei X; Bartneck M; Fech V; Heymann F; Gassler N; Hittatiya K; Eulberg D; Luedde T; Trautwein C; Tacke F
Hepatology; 2014 Mar; 59(3):1060-72. PubMed ID: 24481979
[TBL] [Abstract][Full Text] [Related]
3. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
[TBL] [Abstract][Full Text] [Related]
4. Monocytes and macrophages as cellular targets in liver fibrosis.
Heymann F; Trautwein C; Tacke F
Inflamm Allergy Drug Targets; 2009 Sep; 8(4):307-18. PubMed ID: 19534673
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Krenkel O; Puengel T; Govaere O; Abdallah AT; Mossanen JC; Kohlhepp M; Liepelt A; Lefebvre E; Luedde T; Hellerbrand C; Weiskirchen R; Longerich T; Costa IG; Anstee QM; Trautwein C; Tacke F
Hepatology; 2018 Apr; 67(4):1270-1283. PubMed ID: 28940700
[TBL] [Abstract][Full Text] [Related]
6. Targeting hepatic macrophages to treat liver diseases.
Tacke F
J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
[TBL] [Abstract][Full Text] [Related]
7. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
8. Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo.
Tacke F
Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S27. PubMed ID: 23259611
[TBL] [Abstract][Full Text] [Related]
9. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.
Heymann F; Hammerich L; Storch D; Bartneck M; Huss S; Rüsseler V; Gassler N; Lira SA; Luedde T; Trautwein C; Tacke F
Hepatology; 2012 Mar; 55(3):898-909. PubMed ID: 22031018
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Heterogeneity in Kidney Injury and Fibrosis.
Wen Y; Yan HR; Wang B; Liu BC
Front Immunol; 2021; 12():681748. PubMed ID: 34093584
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
12. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
[TBL] [Abstract][Full Text] [Related]
13. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
[TBL] [Abstract][Full Text] [Related]
14. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.
Ramachandran P; Pellicoro A; Vernon MA; Boulter L; Aucott RL; Ali A; Hartland SN; Snowdon VK; Cappon A; Gordon-Walker TT; Williams MJ; Dunbar DR; Manning JR; van Rooijen N; Fallowfield JA; Forbes SJ; Iredale JP
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):E3186-95. PubMed ID: 23100531
[TBL] [Abstract][Full Text] [Related]
15. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
16. Macrophage autophagy protects against liver fibrosis in mice.
Lodder J; Denaës T; Chobert MN; Wan J; El-Benna J; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F
Autophagy; 2015; 11(8):1280-92. PubMed ID: 26061908
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Phenotype in Liver Injury and Repair.
Sun YY; Li XF; Meng XM; Huang C; Zhang L; Li J
Scand J Immunol; 2017 Mar; 85(3):166-174. PubMed ID: 27491503
[TBL] [Abstract][Full Text] [Related]
18. Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease.
Bartneck M; Fech V; Ehling J; Govaere O; Warzecha KT; Hittatiya K; Vucur M; Gautheron J; Luedde T; Trautwein C; Lammers T; Roskams T; Jahnen-Dechent W; Tacke F
Hepatology; 2016 Apr; 63(4):1310-24. PubMed ID: 26699087
[TBL] [Abstract][Full Text] [Related]
19. Hepatic macrophages: Key players in the development and progression of liver fibrosis.
Cheng D; Chai J; Wang H; Fu L; Peng S; Ni X
Liver Int; 2021 Oct; 41(10):2279-2294. PubMed ID: 33966318
[TBL] [Abstract][Full Text] [Related]
20. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
